NuEyes announced that its NuLoupes augmented reality loupes have received approval from the FDA.
NuEyes announced that its augmented reality loupes, NuLoupes, is now patent-pending and has received FDA approval.
NuLoupes combines 3D stereoscopic technology with design, offering practitioners in dentistry and medicine greater precision and live 3D visualization.
Moving from traditional fixed magnification to the NuLoupes high-resolution variable digital magnification will provide surgeons and dentists with more versatility and viewing area. Using NuEyes’ proprietary patent-pending camera system NuLoupes will provide live 3D stereoscopic imaging with near-zero latency.
The camera system will deliver sub-millimeter accurate depth perception to allow physicians to accurately understand the environment they are viewing. The technology is key to providing natural viewing with enhanced magnification of detailed work in front of the users.
NuLoupes is the first pair of smart glasses that feature live 3D stereoscopic imaging to receive FDA clearance, according to NuEyes, and for a short time NuEyes will be offering a limited amount of NuLoupes developer kits for software developers, clinicians who are developing their medical applications or for those who wants to get first adopter access to NuLoupes before they come to market.
The NuLoupes developer kit will come with a complete SDK that gives exclusive access to the NuLoupes 3D stereoscopic camera sensors, IR sensor, IMU, android operating system, Unity plug-ins, and more to be announced soon. The developer kits are projected to ship in Q1 2024.
“We are thrilled to announce the FDA approval of NuLoupes, a testament to our commitment to innovation and excellence in the medical technology field,” said Mark Greget, founder and chief executive officer of NuEyes. “NuLoupes represents a huge leap forward in visualization technology, and we are confident that they will revolutionize the way medical professionals approach their work.”
Photo courtesy of NuEyes
